Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bonfrer

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 30, 1987
Improved method for the quantification of aminoglutethimide in urine samplesO van Tellingen, J M Bonfrer, W J Nooyen, et al.
British Journal of Cancer|July 2, 1998
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaJ M Bonfrer, C M Korse, O E Nieweg, et al.
Journal of Steroid Biochemistry|September 1, 1984
Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancerP F Bruning, J M Bonfrer, M De Jong-Bakker, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 1999
Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesotheliomaH Schouwink, C M Korse, J M Bonfrer, et al.
Melanoma Research|February 6, 2003
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanomaA P Hamberg, C M Korse, J M Bonfrer, et al.
Anticancer Research|July 1, 1997
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancerK N Gaarenstroom, J M Bonfrer, C M Korse, et al.
Cancer Research|May 1, 1986
MAM-6 antigen, a new serum marker for breast cancer monitoringJ Hilkens, V Kroezen, J M Bonfrer, et al.
Seminars in Oncology|February 1, 1992
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancerN van Zandwijk, E Jassem, J M Bonfrer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1993
Highly elevated serum CA 125 levels in a patient with cardiac failureE H Hopman, T J Helmerhorst, J M Bonfrer, et al.
Anticancer Research|May 1, 1997
Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigenJ M Bonfrer, K N Gaarenstroom, C M Korse, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 30, 1987
Improved method for the quantification of aminoglutethimide in urine samplesO van Tellingen, J M Bonfrer, W J Nooyen, et al.
British Journal of Cancer|July 2, 1998
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaJ M Bonfrer, C M Korse, O E Nieweg, et al.
Journal of Steroid Biochemistry|September 1, 1984
Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancerP F Bruning, J M Bonfrer, M De Jong-Bakker, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 1999
Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesotheliomaH Schouwink, C M Korse, J M Bonfrer, et al.
Melanoma Research|February 6, 2003
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanomaA P Hamberg, C M Korse, J M Bonfrer, et al.
Anticancer Research|July 1, 1997
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancerK N Gaarenstroom, J M Bonfrer, C M Korse, et al.
Cancer Research|May 1, 1986
MAM-6 antigen, a new serum marker for breast cancer monitoringJ Hilkens, V Kroezen, J M Bonfrer, et al.
Seminars in Oncology|February 1, 1992
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancerN van Zandwijk, E Jassem, J M Bonfrer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1993
Highly elevated serum CA 125 levels in a patient with cardiac failureE H Hopman, T J Helmerhorst, J M Bonfrer, et al.
Anticancer Research|May 1, 1997
Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigenJ M Bonfrer, K N Gaarenstroom, C M Korse, et al.
Pageof 5